Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.15% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4501
Southern First Bancshares
SFST
$586M
| $2.78M | ﹤0.01% |
54,052
+4,744
| +10% | +$227K |
|
|
AUTL
4502
Autolus Therapeutics
AUTL
$378M
| $2.78M | ﹤0.01% |
1,397,251
+183,478
| +15% | +$282K |
|
4503
Dimensional US Core Equity Market ETF
DFAU
$12.2B
| $2.78M | ﹤0.01% |
59,296
+14,543
| +32% | +$674K |
|
4504
ProShares VIX Mid-Term Futures ETF
VIXM
$56.2M
| $2.77M | ﹤0.01% |
181,426
+24,474
| +16% | +$392K |
|
4505
First Business Financial Services
FBIZ
$574M
| $2.77M | ﹤0.01% |
50,923
+10,354
| +26% | +$541K |
|
4506
ProQR Therapeutics
PRQR
$243M
| $2.76M | ﹤0.01% |
1,367,119
-1,534,083
| -53% | -$3.59M |
|
4507
CS Disco
LAW
$278M
| $2.76M | ﹤0.01% |
355,218
+78,224
| +28% | +$552K |
|
|
EARN
4508
Ellington Residential Mortgage REIT
EARN
$167M
| $2.75M | ﹤0.01% |
521,666
+397,993
| +322% | +$2.08M |
|
|
NLOP
4509
Net Lease Office Properties
NLOP
$175M
| $2.75M | ﹤0.01% |
106,515
+1,110
| +1% | +$31.4K |
|
|
RFM
4510
RiverNorth Flexible Municipal Income Fund
RFM
$89M
| $2.74M | ﹤0.01% |
196,392
+58,331
| +42% | +$832K |
|
4511
HBT Financial
HBT
$1.33B
| $2.74M | ﹤0.01% |
106,100
+24,746
| +30% | +$611K |
|
|
CMDB
4512
Costamare Bulkers Holdings
CMDB
$448M
| $2.74M | ﹤0.01% |
177,697
-3,485
| -2% | -$50.5K |
|
|
NREF
4513
NexPoint Real Estate Finance
NREF
$321M
| $2.74M | ﹤0.01% |
194,271
+28,836
| +17% | +$403K |
|
4514
Vanguard Short-Term Tax-Exempt Bond ETF
VTES
$2.08B
| $2.74M | ﹤0.01% |
26,927
+25,766
| +2,219% | +$2.62M |
|
4515
Smith & Wesson
SWBI
$649M
| $2.73M | ﹤0.01% |
276,712
-8,383
| -3% | -$80.9K |
|
4516
Lincoln Educational Services
LINC
$1.38B
| $2.72M | ﹤0.01% |
112,821
-115,903
| -51% | -$2.53M |
|
4517
iShares MSCI Agriculture Producers ETF
VEGI
$153M
| $2.72M | ﹤0.01% |
70,549
-16,050
| -19% | -$626K |
|
4518
ALPS Medical Breakthroughs ETF
SBIO
$200M
| $2.72M | ﹤0.01% |
53,101
+4,437
| +9% | +$205K |
|
4519
Finance of America Companies
FOA
$214M
| $2.71M | ﹤0.01% |
112,083
-72,444
| -39% | -$1.65M |
|
|
GCV
4520
Gabelli Convertible and Income Securities Fund
GCV
$89.7M
| $2.7M | ﹤0.01% |
651,280
-51,603
| -7% | -$218K |
|
4521
CVRx
CVRX
$134M
| $2.7M | ﹤0.01% |
380,641
-50,910
| -12% | -$465K |
|
|
GREK
4522
Global X MSCI Greece ETF
GREK
$291M
| $2.7M | ﹤0.01% |
40,925
+7,129
| +21% | +$464K |
|
|
CLDT
4523
Chatham Lodging
CLDT
$630M
| $2.7M | ﹤0.01% |
396,057
+18,731
| +5% | +$124K |
|
|
DFP
4524
Flaherty & Crumrine Dynamic Preferred and Income Fund
DFP
$425M
| $2.69M | ﹤0.01% |
129,167
-1,568
| -1% | -$33.4K |
|
4525
Entrada Therapeutics
TRDA
$245M
| $2.68M | ﹤0.01% |
260,251
-86,505
| -25% | -$729K |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,948 increased, 2,961 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.